Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status.
Formisano L, D'Amato V, Servetto A, Brillante S, Raimondo L, Di Mauro C, Marciano R, Orsini RC, Cosconati S, Randazzo A, Parsons SJ, Montuori N, Veneziani BM, De Placido S, Rosa R, Bianco R.
Formisano L, et al. Among authors: parsons sj.
Oncotarget. 2015 Sep 22;6(28):26090-103. doi: 10.18632/oncotarget.4636.
Oncotarget. 2015.
PMID: 26325669
Free PMC article.